EyePoint (EYPT) Free Cash Flow (2010 - 2026)
EyePoint (EYPT) reported Free Cash Flow of -$80.6 million for Q1 2026, down 51.7% on a YoY basis from -$167.0 million in Q1 2025, and down 18.18% sequentially from -$68.2 million in Q4 2025.
EyePoint (EYPT) Free Cash Flow (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Free Cash Flow data on file, last reported at -$80.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 51.7% year-over-year to -$80.6 million; the trailing twelve-month figure through Mar 2026 stood at -$270.9 million (down 78.52% YoY), and the FY2025 full-year result was -$243.4 million, down 86.82% from the prior year.
- Free Cash Flow fell to -$80.6 million in Q1 2026, from -$68.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $57.5 million in Q2 2023 to a low of -$80.6 million in Q1 2026.
- A 5-year average of -$30.6 million and a median of -$23.1 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow surged 397.33% in 2023 and slumped 215.19% in 2025, its largest moves.
- Tracing EYPT's Free Cash Flow over 5 years: stood at -$13.2 million in 2022, then slumped by 75.43% to -$23.1 million in 2023, then plunged by 62.18% to -$37.5 million in 2024, then sank by 82.08% to -$68.2 million in 2025, then fell by 18.18% to -$80.6 million in 2026.
- Business Quant data shows EYPT's Free Cash Flow at -$80.6 million in Q1 2026, -$68.2 million in Q4 2025, and -$59.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -80.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.65 Mn |
| Mar 31, 2026 | -80.65 Mn |
| Dec 31, 2025 | -68.24 Mn |
| Dec 31, 2025 | -68.24 Mn |
| Sep 30, 2025 | -59.38 Mn |
| Sep 30, 2025 | -59.38 Mn |
| Jun 30, 2025 | -62.61 Mn |
| Jun 30, 2025 | -62.61 Mn |
| Mar 31, 2025 | -53.16 Mn |
| Mar 31, 2025 | -53.16 Mn |
| Dec 31, 2024 | -37.48 Mn |
| Dec 31, 2024 | -37.48 Mn |
| Sep 30, 2024 | -41.23 Mn |
| Sep 30, 2024 | -41.23 Mn |
| Jun 30, 2024 | -19.86 Mn |
| Jun 30, 2024 | -19.86 Mn |
| Mar 31, 2024 | -31.71 Mn |
| Mar 31, 2024 | -31.71 Mn |
| Dec 31, 2023 | -23.11 Mn |
| Dec 31, 2023 | -23.11 Mn |